You are currently viewing a new version of our website. To view the old version click .

Vaccines, Volume 8, Issue 1

March 2020 - 144 articles

Cover Story: Multiplex PCR-based neutralization (MPBN) assay for anti-poliovirus antibodies’ titration uses a quantitative multiplex one-step RT-PCR as a read out instead of the cytopathic effect used in conventional neutralization assay. The MPBN is the first neutralization assay that specifically titrates anti-poliovirus antibodies against the three serotypes of the virus in the same reaction, and it can be completed in two to three days instead of the ten days needed for the conventional assay, as well as automated for high-throughput implementation. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (144)

  • Article
  • Open Access
7 Citations
3,615 Views
15 Pages

Comparisons of Antibody Populations in Different Pre-Fusion F VLP-Immunized Cotton Rat Dams and Their Offspring

  • Lori M. Cullen,
  • Marina S. Boukhvalova,
  • Jorge C. G. Blanco and
  • Trudy G. Morrison

18 March 2020

Respiratory syncytial virus (RSV) infection poses a significant risk for infants. Since the direct vaccination of infants is problematic, maternal vaccination may provide a safer, more effective approach to their protection. In the cotton rat (CR) mo...

  • Article
  • Open Access
50 Citations
8,080 Views
18 Pages

Rapid and Broad Immune Efficacy of a Recombinant Five-Antigen Vaccine against Staphylococcus aureus Infection in Animal Models

  • Hao Zeng,
  • Feng Yang,
  • Qiang Feng,
  • Jinyong Zhang,
  • Jiang Gu,
  • Haiming Jing,
  • Changzhi Cai,
  • Liming Xu,
  • Xi Yang and
  • Xin Xia
  • + 3 authors

18 March 2020

Staphylococcus aureus (S. aureus) is a leading cause of both healthcare-and community-associated infections globally, which result in severe disease and readily developing antibiotic resistance. Developing an efficacious vaccine against S. aureus is...

  • Review
  • Open Access
18 Citations
7,997 Views
12 Pages

17 March 2020

Optimal vaccine dosing is important to ensure the greatest protection and safety. Analysis of dose-response data, from previous studies, may inform future studies to determine the optimal dose. Implementing more quantitative modelling approaches in v...

  • Review
  • Open Access
132 Citations
11,968 Views
23 Pages

17 March 2020

Streptococcus pneumoniae is a major pathogen causing pneumonia with over 2 million deaths annually, especially in young children and the elderly. To date, at least 98 different pneumococcal capsular serotypes have been identified. Currently, the vacc...

  • Article
  • Open Access
11 Citations
5,101 Views
16 Pages

An Antibody Persistent and Protective Two rSsCLP-Based Subunit Cocktail Vaccine against Sarcoptes scabiei in a Rabbit Model

  • Nengxing Shen,
  • Wenrui Wei,
  • Yuhang Chen,
  • Yongjun Ren,
  • Lang Xiong,
  • Yuanyuan Tao,
  • Xiaobin Gu,
  • Yue Xie,
  • Xuerong Peng and
  • Guangyou Yang

16 March 2020

Scabies is a highly contagious disease caused by Sarcoptes scabiei which burrows into stratum corneum of host’s skin. In this study, after optimizing vaccination schedule, a vaccination trial is comprised of three test groups of rabbits (n = 10...

  • Article
  • Open Access
18 Citations
5,829 Views
18 Pages

Design of an Epitope-Based Vaccine Ensemble for Animal Trypanosomiasis by Computational Methods

  • Lucas Michel-Todó,
  • Pascal Bigey,
  • Pedro A Reche,
  • María-Jesus Pinazo,
  • Joaquim Gascón and
  • Julio Alonso-Padilla

16 March 2020

African animal trypanosomiasis is caused by vector-transmitted parasites of the genus Trypanosoma. T. congolense and T. brucei brucei are predominant in Africa; T. evansi and T. vivax in America and Asia. They have in common an extracellular lifestyl...

  • Article
  • Open Access
3 Citations
4,010 Views
12 Pages

Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine

  • Lilin Lai,
  • Nadine Rouphael,
  • Yongxian Xu,
  • Amy C. Sherman,
  • Srilatha Edupuganti,
  • Evan J. Anderson,
  • Pamela Lankford-Turner,
  • Dongli Wang,
  • Wendy Keitel and
  • Monica M. McNeal
  • + 4 authors

13 March 2020

The cellular immune responses elicited by an investigational vaccine against an emergent variant of influenza (H3N2v) are not fully understood. Twenty-five subjects, enrolled in an investigational influenza A/H3N2v vaccine study, who received two dos...

  • Article
  • Open Access
10 Citations
5,872 Views
19 Pages

Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized with DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins

  • Juan García-Arriaza,
  • María Q. Marín,
  • Jesús Merchán-Rubira,
  • Sara M. Mascaraque,
  • Miguel Medina,
  • Jesús Ávila,
  • Félix Hernández and
  • Mariano Esteban

13 March 2020

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by a progressive memory loss and cognitive decline that has been associated with an accumulation in the brain of intracellular neurofibrillary tangles (NFTs) formed by hyper...

  • Review
  • Open Access
145 Citations
19,489 Views
20 Pages

13 March 2020

Traditional aluminum adjuvants can trigger strong humoral immunity but weak cellular immunity, limiting their application in some vaccines. Currently, various immunomodulators and delivery carriers are used as adjuvants, and the mechanisms of action...

  • Review
  • Open Access
28 Citations
9,726 Views
21 Pages

Safety of Administering Live Vaccines during Pregnancy: A Systematic Review and Meta-Analysis of Pregnancy Outcomes

  • Almudena Laris-González,
  • Daniel Bernal-Serrano,
  • Alexander Jarde and
  • Beate Kampmann

11 March 2020

Live-attenuated vaccines (LAV) are currently contraindicated during pregnancy, given uncertain safety records for the mother–infant pair. LAV might, however, play an important role to protect them against serious emerging diseases, such as Ebol...

of 15

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X